Lu AG22515

DRUG2 trials

Sponsors

H. Lundbeck A/S

Conditions

Healthy ParticipantsThyroid Eye Disease

Phase 1

A Study Investigating Lu AG22515 in Healthy Adults

CompletedNCT05136053

H. Lundbeck A/SHealthy Participants

Start: 2022-03-18End: 2023-08-05Updated: 2023-08-28

A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease

Active, not recruitingNCT06557850

H. Lundbeck A/SThyroid Eye Disease

Start: 2024-09-19End: 2026-09-29Updated: 2026-09-09